19 March 2018
News and Views
Links and Services
The latest Alimentary Pharmacology & Therapeutics developed interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.
Patient-reported outcomes have an increasingly important role in the evaluation of new therapies
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors